Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis

Journal of Medical Imaging and Radiation Oncology

Volumn 56, Issue 1, 2012, Pages 66-74

  Chen, Yue Hong ^a   Yang, Xin Ming ^a   Li, Shi Sheng ^a   Wang, Yuan Hua ^a   He, Jian Jun ^a   Yang, Yi Da ^b   Wang, Shuang ^a   Liu, Jia Jia ^a   Zhang, Xiao Li ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

carcinoma of unknown primary; FDG PET CT; neck lymph node metastasis; primary tumour detection.

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; PREDICTIVE VALUE; PRIMARY TUMOR; PRIMARY UNKNOWN CERVICAL LYMPH NODE METASTASIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOPSY; ENDOSCOPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOSCINTIGRAPHY; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOGRAPHY, ABDOMINAL; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863166271     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2011.02331.x     Document Type: Article

References (26)

1. Kwee TC, Basu S, Cheng G, Alavi A,. FDG PET-CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2009; 37: 635-44.
2. Muir C,. Cancer of unknown primary site. Cancer 1995; 75: 353-6.
3. Pavlidis N, Fizazi K,. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 2009; 69: 271-8.
4. Neben K, Hübner G, Folprecht G, Jäger D, Krämer A,. Metastases in the absence of a primary tumor: advances in the diagnosis and treatment of CUP syndrome. Dtsch Arztebl Int 2008; 105: 733-40.
5. Randall D, Johnstone P, Foss R, Martin P,. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg 2000; 122: 52-5. (Pubitemid 30051689)
6. Haas I, Hoffmann TK, Engers R, Ganzer U,. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 2002; 259: 325-33. (Pubitemid 34762310)
7. Freudenberg LS, Fischer M, Antoch G, et al,. Dual modality of 18Ffluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract 2005; 14: 155-60. (Pubitemid 40663292)
8. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G,. PET-CT for the staging and follow-up of patients with malignancies. Eur J Radiol 2009; 70: 382-92.
9. Kirschner MJ, Fietkau R, Waldfahrer F, Iro H, Sauer R,. Therapy of cervical lymph node metastases of unknown primary tumor. Strahlenther Onkol 1997; 173: 362-8. (Pubitemid 27305293)
10. Issing WJ, Taleban B, Tauber S,. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 2003; 260: 436-43. (Pubitemid 37267037)
11. De Braud F, Heilbrun LK, Ahmed K, et al,. Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment. Cancer 1989; 64: 510-5. (Pubitemid 19180415)
12. Loh KS, Brown DH, Baker JT, Gilbert RW, Gullane PJ, Irish JC,. A rational approach to pulmonary screening in newly diagnosed head and neck cancer. Head Neck 2005; 27: 990-4. (Pubitemid 41552145)
13. Ravenel JG, Costello P, Silvestri GA,. Screening for lung cancer. AJR Am J Roentgenol 2008; 190: 755-61. (Pubitemid 351304522)
14. Kothari P, Randhawa PS, Farrell R,. Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown primary in the head and neck. Br J Oral Maxillofac Surg 2008; 46: 283-7. (Pubitemid 351625794)
15. Nassenstein K, Veit-Haibach P, Stergar H, et al,. Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography. Acta Radiol 2007; 23: 1-8.
16. Fakhry N, Barberet M, Lussato D, et al,. Role of [18F]-FDG PET-CT in the management of the head and neck cancers. Bull Cancer 2006; 93: 1017-25. (Pubitemid 44744619)
17. Kwee TC, Kwee RM,. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 2009; 19: 731-44.
18. Wei WI, Kwong DL,. Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol 2010; 3: 1-12.
19. Fandi A, Altun M, Azli N, et al,. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol 1994; 21 (3): 382-97. (Pubitemid 24191598)
20. Ryan WR, Fee WE Jr, Le QT, Pinto HA,. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005; 115: 645-50. (Pubitemid 40530014)
21. Kluetz PG, Meltzer CC, Villemagne VL, et al,. Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 2000; 3: 223-30.
22. Jansma J, Vissink A, Spijkervet FK, et al,. Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 1992; 15: 2171-80.
23. Chao KS, Deasy JO, Markman J, et al,. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 49: 907-16. (Pubitemid 32184597)
24. Nutting C, A'Hern R, Rogers MS, et al,. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J Clin Oncol 2009; 27: 18S. (abstr LBA6006).
25. Feng FY, Kim HM, Lyden TH, et al,. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-98. (Pubitemid 47176817)
26. Heron DE, Andrade RS, Beriwal S, Smith RP,. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response. Am J Clin Oncol 2008; 31: 352-62.